Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D001795:Blood Pressure Determination; D002415:Cats; D003214:Conditioning, Classical / Q000187:drug effects; D004361:Drug Tolerance; D004566:Electrodes; D004569:Electroencephalography; D004597:Electroshock; D004924:Escape Reaction / Q000187:drug effects; D006168:Guinea Pigs; D006213:Hallucinogens / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008635:Mescaline / Q000494:pharmacology; D008694:Methamphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010649:Phenylalanine; D011562:Psilocybin / Q000494:pharmacology; D013045:Species Specificity; D014363:Tryptamines / Q000494:pharmacology
D006213:Hallucinogens; D014363:Tryptamines; D011562:Psilocybin; D008694:Methamphetamine; D010649:Phenylalanine; D008238:Lysergic Acid Diethylamide; D006899:Mixed Function Oxygenases; D008635:Mescaline